Pnc Financial Services Group, Inc. Gilead Sciences, Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 390,175 shares of GILD stock, worth $35.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

390,175

Previous 362,892 7.52%

Holding current value

$35.1 Million

Previous $24.9 Million 31.35%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $1.82 Million - $2.29 Million	27,283 Added 7.52%	390,175 $32.7 Million
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $238,896 - $275,705	-3,783 Reduced 1.03%	362,892 $24.9 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $801,194 - $977,036	-11,193 Reduced 2.96%	366,675 $26.9 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $347,666 - $394,262	4,745 Added 1.27%	377,868 $30.6 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $48,726 - $53,161	-659 Reduced 0.18%	373,123 $28 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $694,883 - $792,611	-9,142 Reduced 2.39%	373,782 $28.8 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1.21 Million - $1.38 Million	-15,643 Reduced 3.92%	382,924 $31.8 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $580,510 - $833,413	-9,315 Reduced 2.28%	398,567 $34.2 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $291,805 - $333,317	4,901 Added 1.22%	407,882 $25.2 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $763,231 - $859,627	-13,223 Reduced 3.18%	402,981 $24.9 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $1.2 Million - $1.5 Million	-20,651 Reduced 4.73%	416,204 $24.7 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $1.42 Million - $1.61 Million	21,813 Added 5.26%	436,855 $31.7 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $256,071 - $276,272	-3,783 Reduced 0.9%	415,042 $29 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $120,593 - $131,765	-1,900 Reduced 0.45%	418,825 $28.8 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $8,820 - $10,063	-147 Reduced 0.03%	420,725 $27.2 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.93 Million - $2.19 Million	33,983 Added 8.78%	420,872 $24.5 Million
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $66,819 - $84,014	-1,076 Reduced 0.28%	386,889 $24.4 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $1.34 Million - $1.55 Million	-18,501 Reduced 4.55%	387,965 $29.9 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $767,969 - $983,657	12,262 Added 3.11%	406,466 $30.4 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $1.51 Million - $1.66 Million	-24,541 Reduced 5.86%	394,204 $25.6 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $2.04 Million - $2.25 Million	32,629 Added 8.45%	418,745 $26.5 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $1.43 Million - $1.6 Million	-23,054 Reduced 5.63%	386,116 $0
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $414,761 - $464,641	6,633 Added 1.65%	409,170 $0
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $4.86 Million - $6.34 Million	-80,252 Reduced 16.62%	402,537 $25.2 Million
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $3.39 Million - $3.75 Million	-47,512 Reduced 8.96%	482,789 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $1.48 Million - $1.72 Million	-22,739 Reduced 4.11%	530,301 $0
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $366,967 - $447,374	5,038 Added 0.92%	553,040 $0
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $7.32 Million - $8.59 Million	-102,864 Reduced 15.8%	548,002 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $46.9 Million - $55.6 Million	650,866	650,866 $0

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Gilead Sciences, Inc. Transaction History